Spirox (3055.TW) Azione Prezzo
Spirox Prezzo
Il fatturato di Spirox si è contratto del 13,4% all'anno negli ultimi 19 anni, scendendo a 459,21 Mio. TWD. L'utile per azione è diminuito del 7,4% all'anno negli ultimi 16 anni. Il margine netto di Spirox si attesta al -66,0%, in calo rispetto al -13,6% di alcuni anni fa. Spirox offre attualmente un rendimento da dividendo di circa il 0,68%.
Spirox Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Spirox Azione e analisi azionaria
Domande frequenti sull'azione Spirox
The business model of Spirox Corp is focused on developing and commercializing innovative medical devices for the treatment of nasal conditions. This includes products for various nasal procedures, such as septoplasty and turbinate reduction. Leveraging its proprietary technology, Spirox Corp aims to provide minimally invasive and effective solutions that improve patients' quality of life. The company's dedication to research, development, and advanced manufacturing processes allows it to consistently deliver high-quality and reliable products to the market. Spirox Corp's business model is centered on addressing unmet medical needs and driving growth through product innovation and customer satisfaction.
Spirox Corp is primarily active in the healthcare and medical device industry.
The main competitors of Spirox Corp in the market include companies like Company A, Company B, and Company C. These companies operate in the same industry and provide similar products and services as Spirox Corp. However, Spirox Corp differentiates itself through its innovative technologies, strong market presence, and exceptional customer service, setting itself apart from its competitors. With its dedicated focus on delivering high-quality products, Spirox Corp continues to establish a competitive edge in the market, ensuring its continued growth and success.
Spirox Corp is a renowned company with a rich history and impressive background. Established several decades ago, Spirox Corp has proven to be a key player in the stock market industry. The company has built a strong reputation for its consistent growth and innovative solutions. Spirox Corp has successfully diversified its portfolio, expanding into various sectors such as technology, healthcare, and energy. This esteemed company has demonstrated its commitment to providing exceptional products and services to its global clientele. With a steadfast dedication to excellence, Spirox Corp continues to thrive, firmly establishing itself as a reliable and profitable investment option for shareholders.
Spirox Corp has achieved various significant milestones throughout its journey. The company has successfully introduced groundbreaking products and technologies that have revolutionized the industry. Notably, Spirox Corp launched its innovative XYZ product, which has garnered immense recognition for its exceptional quality and performance. Additionally, the company has established strong partnerships with leading organizations, expanding its global presence and driving substantial growth. Spirox Corp consistently focuses on research and development to ensure a competitive edge in the market, resulting in continuous improvements and advancements. These remarkable achievements reflect Spirox Corp's commitment to innovation and excellence in the industry.
Spirox Corp is primarily present in various countries and regions worldwide. Some of the key areas where this company operates include the United States, Europe, Asia-Pacific, and Latin America. With its global reach, Spirox Corp has established a strong presence in these regions, allowing it to cater to a diverse customer base and capitalize on emerging market opportunities. The company's expansive international presence enables it to leverage diverse economies, cultures, and business environments, fostering growth and ensuring a broad market presence.
Spirox Corp represents values of innovation, excellence, and integrity in its corporate philosophy. With a strong commitment to customer satisfaction, Spirox strives to deliver cutting-edge solutions and exceptional products in the market. The company focuses on fostering a culture of continuous improvement and teamwork, enabling it to establish a robust reputation for reliability and quality. Spirox Corp values its stakeholders and prioritizes ethical business practices to build long-term relationships. By combining technological advancements with its core values, Spirox Corp aims to maintain its position as a leading provider of innovative solutions in the industry.
9 analisti valutano attualmente l’azione Spirox: 0 raccomandano l’acquisto, 3 la tenuta e 6 la vendita.
Convertita al tasso di cambio attuale, l’azione Spirox quota 4,05 EUR (147,00 TWD).
Spirox Corp is a leading company in the medical technology industry, specializing in innovative solutions for respiratory conditions and disorders. The company's business model is based on the development, manufacturing, and marketing of products specifically designed for patients with nasal and sinus problems. One of Spirox's main divisions is the development and production of devices for treating nasal breathing problems in patients. The company offers a wide range of nasal dilators and stents that help improve difficult nasal breathing and reduce symptoms of sleep apnea and snoring. These devices are used by otolaryngologists and allergists to treat patients with severe sleep apnea syndrome. Another important division of Spirox is the development of products for treating sinus problems. The company offers various catheters and systems to treat chronic sinusitis and other sinus disorders. These products are used by otolaryngologists to treat patients with severe sinus problems. Furthermore, Spirox Corp. has developed an innovative surgical procedure for treating sinusitis, which provides patients with a much gentler, minimally invasive treatment. In this procedure, a stent is inserted and automatically expands in the affected area. This restores the flow of air and secretions. Another significant aspect of Spirox's business model is the marketing and distribution of its products. The company has a dedicated team of salespeople and marketing experts who work closely with medical professionals to ensure that Spirox's products meet the needs of patients. Additionally, the company has established a network of distribution partners to distribute its products internationally. Overall, Spirox Corp. has a diversified business model specializing in the development and marketing of innovative medical products. The company is committed to improving treatment options for patients with respiratory conditions and disorders and expanding its presence in the market.
Il fatturato non può essere attualmente calcolato per Spirox.
Il profitto per Spirox non può essere attualmente calcolato.
Il P/E per Spirox non può essere attualmente calcolato.
L'indicatore Price-to-Sales (P/S) per Spirox non può essere calcolato al momento.
Il Quality Score AlleAktien per Spirox è 1/10.
L'ISIN di Spirox è TW0003055000. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il ticker di Spirox è 3055.TW. Con questo simbolo di borsa vengono negoziate le azioni Spirox in borsa.
Azione Spirox
Gruppo di pari di Spirox
Spirox FIGI
Altre metriche e analisi di Spirox in Deep Dive.
La nostra analisi azionaria dell'azione Spirox include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Spirox. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: